Liu, Pei
Liu, Ningning
Jia, Gaoding
Li, Haimei
Wang, Yufeng
Liu, Lu
Niu, Haijing
Qian, Qiujin
Funding for this research was provided by:
National Science Foundation of China (81571340,81873802,82271575)
Capita’s Funds for Health Improvement and Research (CFH: 2020-2-4112;2022-2-4114)
National Basic Research Program of China (2014CB846104)
CAMS Innovation Fund for Medical Sciences (2017-I2M-3-003)
Article History
Accepted: 14 June 2023
First Online: 19 July 2023
Declarations
:
: The present study was conducted under the guidelines of the <i>Declaration of Helsinki</i>. This study was approved by the Institutional Review Board of Peking University Sixth Hospital and written informed consent was obtained before participants joined the study, and all participants signed consent on participating and data publishing. The trial has been registered at Chinese Clinical Trial Register at the number ChiCTR1800019215.
: Written informed consent was obtained before participants who joined the study, and all participants signed consent on data publishing.
: The authors declare no competing interests.